Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Comparison of Viral Suppression With 0.5 mg and 1.0 mg Daily Doses of Entecavir in Decompensated HBV Cirrhosis of Liver

NCT07816094 is registered in ClinicalTrials.gov with Bangladesh Medical University as lead sponsor.

NCT NCT07816094
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07816094 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Comparison of Viral Suppression With 0.5 mg and 1.0 mg Daily Doses of Entecavir in Decompensated HBV Cirrhosis of Liver
Lead sponsor
Bangladesh Medical University
Phase
Phase 4
Overall status
Recruiting
Start date
January 1, 2026
Completion date
January 19, 2027
Enrollment
48 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hepatitis b